One in 59 children in the United States lives with a form of autism spectrum disorder, according to the Centers for Disease Control and Prevention. The signs of autism begin in early childhood and can affect individuals differently.
However, many with autism share similar symptoms, including difficulties with social communication. Researchers from the University of Missouri School of Medicine and MU Thompson Center for Autism and Neurodevelopment identified a link between a neurotransmitter imbalance and brain connectivity between regions of the brain that play a role in social communication and language. The study found two tests that could lead to more precise medical treatments.
“One of the issues with approaching treatment of autism is there are many subtypes and many different genes and potentially other factors that contribute to the disorder,” said David Beversdorf, MD, professor of radiology, neurology and psychology at the MU School of Medicine and the Thompson Center. “If you have a treatment that works in one sub-population, it might not work in another. However, if we can determine why that is, we can pursue individualized approaches and make a lot more progress in developing new treatments.”
Using both functional magnetic resonance imaging (fMRI) and proton magnetic resonance spectroscopy (H-MRS), John Hegarty, PhD, while a graduate student in the interdisciplinary neuroscience program at MU and now a postdoctoral fellow at Stanford University, led Beversdorf’s team. They investigated the relationship between brain neurotransmitter levels and connectivity of areas of the brain known as the dorsolateral prefrontal cortex and posterolateral cerebellar hemisphere.
Fourteen adolescents and adults with autism spectrum disorder and 12 control participants underwent brain scans. The scans revealed a potential link between functional connectivity, neurotransmitter imbalance, and listening comprehension in individuals with autism. Those with low functional connectivity tended to have a reduced balance of excitatory to inhibitory neurotransmitter levels in the cerebellum and showed impaired listening comprehension, the ability to infer meaning from verbal information. Study participants were administered two questionnaires to determine their autism spectrum disorder-related symptom severity. They also completed two assessments designed to rate different aspects of language and social competence.
“This finding begins to suggest how biomarkers relate with each other in autism,” Beversdorf said. “There may be whole other sets of biomarkers that may be inter-related and may be telling us something. It may serve as a biomarker to predict who will respond to what drug.”
In addition to Beversdorf, the study authors include John Hegarty, PhD, postdoctoral research fellow at the Stanford Autism Center; Dylan Weber, DDS, University of Missouri-Kansas City School of Dentistry; and Carmen Cirstea, MD, PhD, assistant professor of research at the MU School of Medicine.
The study, “Cerebro-Cerebellar Functional Connectivity is Associated with Cerebellar Excitation-Inhibition Balance in Autism Spectrum Disorder,” was recently published in the Journal of Autism and Developmental Disorders. Research reported in this publication was supported by a pilot grant from the University of Missouri Brain Imaging Center, the University of Missouri School of Medicine Mission Enhancement Fund and crowdsourced funding from the community. The authors of the study declare that they have no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the views of the funding agencies.
